Effect of the umami peptides on the ligand binding and function of rat mGlu4a receptor might implicate this receptor in the monosodium glutamate taste transduction

被引:26
作者
Monastyrskaia, K
Lundstrom, K
Plahl, D
Acuna, G
Schweitzer, C
Malherbe, P
Mutel, V [1 ]
机构
[1] F Hoffmann La Roche & Co Ltd, Div Pharma, Preclin CNS Res, CH-4070 Basel, Switzerland
[2] F Hoffmann La Roche Ltd, Roche Genet, CH-4070 Basel, Switzerland
[3] Givaudan Roure Forsch AG, CH-8600 Dubendorf, Switzerland
关键词
Umami peptide; metabotropic glutamate receptor; H-3]-L-AP4; rat mGlu(4a) receptor; gamma-S-35]-GTP binding; radioligand binding; taste transduction;
D O I
10.1038/sj.bjp.0702885
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effect of several metabotropic ligands and di- or tripeptides were tested on the binding of [H-3]-L(+)-2-amino-4-phosphonobutyric acid ([H-3]-L-AP4) on rat mGlu(4) receptor. For selected compounds, the functional activity was determined on this receptor using the guanosine-5'[gamma-S-35]-thiotriphosphate [gamma-S-35]-GTP binding assay. 2 Using the scintillation proximity assay, [H-3]-L-AP4 saturation analysis gave binding parameters K-D and B-max values of 150 nM and 9.3 pmoles mg(-1) protein, respectively. The specific binding was inhibited concentration-dependently by several mGlu receptor ligands, and their rank order of affinity was established. 3 Several peptides inhibited the [H-3]-L-AP4 binding with the following rank order of potency: glutamate-glutamate > glutamate-glutamate-leucine = aspartate - glutamate, > > glutamate - glutamate-aspartate > lactoyl-glutamate > > aspartate-aspartate. Aspartate-phenylalanine-methyl eater (aspartame) was inactive up to 1 mM and guanosine-5'-monophosphate and inosine-5'-monophosphate were inactive up to 100 mu M. 4 The [gamma-S-35]-GTP binding functional assay was used to determine the agonist activities of the different compounds. For the rat mGlu(4) agonists, L-AP4 and L-glutamate, the correlation between their occupancy and activation of the receptor was close to one. The peptides, Glu-Glu, Asp-Glu and Glu-Glu-Asp failed to stimulate the [gamma-S-35]-GTP binding at receptor occupancy greater than 80% and Glu-Glu-Leu appeared to be a weak partial agonist. These peptides did not elicit a clear dose-dependent umami perception. However, Glu-lac showed a good correlation between its potency to stimulate the [gamma-S-35]-GTP binding and its affinity for displacement of [H-3]-L-AP4 binding. These data are in agreement with the peptide taste assessment in human subjects, which showed that the acid derivatives of glutamate had characteristics similar to umami.
引用
收藏
页码:1027 / 1034
页数:8
相关论文
共 36 条
[1]   SIGNAL TRANSDUCTION AND PHARMACOLOGICAL CHARACTERISTICS OF A METABOTROPIC GLUTAMATE RECEPTOR, MGLUR1, IN TRANSFECTED CHO CELLS [J].
ARAMORI, I ;
NAKANISHI, S .
NEURON, 1992, 8 (04) :757-765
[2]   SEMLIKI FOREST VIRUS EXPRESSION SYSTEM - PRODUCTION OF CONDITIONALLY INFECTIOUS RECOMBINANT PARTICLES [J].
BERGLUND, P ;
SJOBERG, M ;
GAROFF, H ;
ATKINS, GJ ;
SHEAHAN, BJ ;
LILJESTROM, P .
BIO-TECHNOLOGY, 1993, 11 (08) :916-920
[3]  
Chaudhari N, 1996, J NEUROSCI, V16, P3817
[4]   Pharmacology and functions of metabotropic glutamate receptors [J].
Conn, PJ ;
Pin, JP .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :205-237
[5]   (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu(5), but not mGlu(1), receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus [J].
Doherty, AJ ;
Palmer, MJ ;
Henley, JM ;
Collingridge, GL ;
Jane, DE .
NEUROPHARMACOLOGY, 1997, 36 (02) :265-267
[6]   [H-3]-L-2-amino-4-phosphonobutyrate labels a metabotropic glutamate receptor, mGluR4a [J].
Eriksen, L ;
Thomsen, C .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (08) :3279-3287
[7]   ARE UMAMI TASTE RECEPTOR-SITES STRUCTURALLY RELATED TO GLUTAMATE CNS RECEPTOR-SITES [J].
FAURION, A .
PHYSIOLOGY & BEHAVIOR, 1991, 49 (05) :905-912
[8]  
FEDOROV A, 1997, SOC NEUR ABSTR
[9]   MOLECULAR-CLONING, FUNCTIONAL EXPRESSION AND PHARMACOLOGICAL CHARACTERIZATION OF THE HUMAN METABOTROPIC GLUTAMATE-RECEPTOR TYPE-4 [J].
FLOR, PJ ;
LUKIC, S ;
RUEGG, D ;
LEONHARDT, T ;
KNOPFEL, T ;
KUHN, R .
NEUROPHARMACOLOGY, 1995, 34 (02) :149-155
[10]  
FREROT EM, 1997, Patent No. 04667